BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol. 1995;142:699-708. [PMID: 7572939 DOI: 10.1093/oxfordjournals.aje.a117699] [Cited by in Crossref: 237] [Cited by in F6Publishing: 210] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Abel T, Fehér J. [Non-alcoholic fatty liver disease and cardiovascular risk]. Orv Hetil. 2008;149:1299-1305. [PMID: 18617457 DOI: 10.1556/OH.2008.28418] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
2 Strasak AM, Pfeiffer RM, Klenk J, Hilbe W, Oberaigner W, Gregory M, Concin H, Diem G, Pfeiffer KP, Ruttmann E, Ulmer H; Vorarlberg Health Monitoring and Promotion Program Study Group. Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women. Int J Cancer. 2008;123:1902-1906. [PMID: 18688855 DOI: 10.1002/ijc.23714] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 4.5] [Reference Citation Analysis]
3 Brea Á, Pintó X, Ascaso JF, Blasco M, Díaz Á, González-Santos P, Hernández Mijares A, Mantilla T, Millán J, Pedro-Botet J; Grupo de trabajo sobre Dislipemia Aterogénica. Sociedad Española de Arteriosclerosis. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (I). Nonalcoholic fatty liver disease and its association with cardiovascular disease. Clin Investig Arterioscler 2017;29:141-8. [PMID: 27692633 DOI: 10.1016/j.arteri.2016.06.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Zhang H, Dickinson DA, Liu RM, Forman HJ. 4-Hydroxynonenal increases gamma-glutamyl transpeptidase gene expression through mitogen-activated protein kinase pathways. Free Radic Biol Med 2005;38:463-71. [PMID: 15649648 DOI: 10.1016/j.freeradbiomed.2004.10.031] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
5 Holme J, Dawkins PA, Stockley EK, Parr DG, Stockley RA. Studies of gamma-glutamyl transferase in alpha-1 antitrypsin deficiency. COPD 2010;7:126-32. [PMID: 20397813 DOI: 10.3109/15412551003631733] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kim DJ, Noh JH, Cho NH, Lee BW, Choi YH, Jung JH, Min YK, Lee MS, Lee MK, Kim KW. Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors. Diabet Med 2005;22:1134-40. [PMID: 16108838 DOI: 10.1111/j.1464-5491.2005.01581.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
7 Ahmed MH, Husain NE, Almobarak AO. Nonalcoholic Fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians? J Family Med Prim Care. 2015;4:45-52. [PMID: 25810989 DOI: 10.4103/2249-4863.152252] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
8 Seet RC, Quek AM, Lim EC, Halliwell B. Biomarkers of oxidative damage are elevated among individuals with high cardiovascular risk: Refining subject selection strategies for antioxidant trials. Free Radical Research 2013;47:283-90. [DOI: 10.3109/10715762.2013.769215] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
9 Yu JH, Kim JS, Lee MR, Yoon SY, Cho SY, Yoo SH, Kim BI. Risks of borderline liver enzyme abnormalities to the incidence of impaired fasting glucose and diabetes mellitus: a 7 year follow up study of workers. Ann Occup Environ Med 2016;28:18. [PMID: 27057316 DOI: 10.1186/s40557-016-0105-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Borodulin K, Laatikainen T, Lahti-Koski M, Lakka TA, Laukkanen R, Sarna S, Jousilahti P. Associations between estimated aerobic fitness and cardiovascular risk factors in adults with different levels of abdominal obesity. Eur J Cardiovasc Prev Rehabil 2005;12:126-31. [PMID: 15785297 DOI: 10.1097/00149831-200504000-00006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.2] [Reference Citation Analysis]
11 Byrne CD. Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management. Diabet Med. 2012;29:1098-1107. [PMID: 22672330 DOI: 10.1111/j.1464-5491.2012.03732.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 7.1] [Reference Citation Analysis]
12 Demirelli S, Firtina S, Askin L, Akgol Gur ST, Tanrikulu CS, Ermis E, Ipek E, Kalkan K, Yildirim E, Kiziltunc A. Utility of γ-Glutamyl Transferase in Predicting Troponin Elevation in Emergency Departments. Angiology 2016;67:737-41. [PMID: 26514415 DOI: 10.1177/0003319715613923] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Bo S, Gambino R, Durazzo M, Guidi S, Tiozzo E, Ghione F, Gentile L, Cassader M, Pagano GF. Associations between gamma-glutamyl transferase, metabolic abnormalities and inflammation in healthy subjects from a population-based cohort: a possible implication for oxidative stress. World J Gastroenterol 2005;11:7109-17. [PMID: 16437656 DOI: 10.3748/wjg.v11.i45.7109] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
14 Choi KM, Han K, Park S, Chung HS, Kim NH, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Park YG, Kim SM. Implication of liver enzymes on incident cardiovascular diseases and mortality: A nationwide population-based cohort study. Sci Rep 2018;8:3764. [PMID: 29491346 DOI: 10.1038/s41598-018-19700-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
15 Lorzadeh E, Akhondi-Meybodi M, Mozaffari-Khosravi H, Mirzaei M, Salehi-Abargouei A. Association between empirically derived dietary patterns and liver function tests in adults: Shahedieh cohort study. Nutrition 2021;81:110897. [PMID: 32738511 DOI: 10.1016/j.nut.2020.110897] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Onat A, Hergenç G, Karabulut A, Türkmen S, Doğan Y, Uyarel H, Can G, Sansoy V. Serum gamma glutamyltransferase as a marker of metabolic syndrome and coronary disease likelihood in nondiabetic middle-aged and elderly adults. Prev Med 2006;43:136-9. [PMID: 16714057 DOI: 10.1016/j.ypmed.2006.04.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
17 Suh BS. The Association between Serum Gamma-Glutamyltransferase within Normal Levels and Metabolic Syndrome in Office Workers: A 4-Year Follow-up Study. Korean J Fam Med 2012;33:51-8. [PMID: 22745888 DOI: 10.4082/kjfm.2012.33.1.51] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
18 Ulus T, Yildirir A, Demirtas S, Demir O, Sade LE, Bozbas H, Gürsoy Y, Bilgi M, Küçük MA, Müderrisoğlu H. Serum gamma-glutamyl transferase activity: A new marker for stent restenosis? Atherosclerosis 2007;195:348-53. [DOI: 10.1016/j.atherosclerosis.2006.09.025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
19 Paolicchi A, Emdin M, Passino C, Lorenzini E, Titta F, Marchi S, Malvaldi G, Pompella A. β-Lipoprotein- and LDL-associated serum γ-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis 2006;186:80-5. [DOI: 10.1016/j.atherosclerosis.2005.07.012] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 3.9] [Reference Citation Analysis]
20 Nakanishi N, Nishina K, Li W, Sato M, Suzuki K, Tatara K. Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. J Intern Med 2003;254:287-95. [DOI: 10.1046/j.1365-2796.2003.01198.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]
21 McCallum L, Panniyammakal J, Hastie CE, Hewitt J, Patel R, Jones GC, Muir S, Walters M, Sattar N, Dominiczak AF, Padmanabhan S. Longitudinal Blood Pressure Control, Long-Term Mortality, and Predictive Utility of Serum Liver Enzymes and Bilirubin in Hypertensive Patients. Hypertension 2015;66:37-43. [PMID: 25941342 DOI: 10.1161/HYPERTENSIONAHA.114.04915] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
22 Adeyemi WJ, Olayaki LA, Abdussalam TA, Toriola AP, Olowu AB, Yakub AJ, Raji AO. Investigation of the effects of dietary modification in experimental obesity: low dose of virgin coconut oil has a potent therapeutic value. Biomed Pharmacother 2020;126:110110. [PMID: 32244146 DOI: 10.1016/j.biopha.2020.110110] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
23 Celik T, Yuksel UC, Kilic S, Yaman H, Iyisoy A, Karaeren H. The relationship of gamma-glutamyltransferase to aortic elastic properties in young patients with prehypertension. Clin Exp Hypertens 2010;32:377-84. [PMID: 21029002 DOI: 10.3109/10641961003628528] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
24 Dominici S, Paolicchi A, Lorenzini E, Maellaro E, Comporti M, Pieri L, Minotti G, Pompella A. γ-Glutamyltransferase-dependent prooxidant reactions: A factor in multiple processes. BioFactors 2003;17:187-98. [DOI: 10.1002/biof.5520170118] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.2] [Reference Citation Analysis]
25 Demirtaş K, Yayla Ç, Sade LE, Yildirir A, Özin MB, Haberal A, Müderrisoğlu IH. Platelet Membrane Γ-Glutamyl Transferase-Specific Activity and the Clinical Course of Acute Coronary Syndrome. Angiology 2019;70:166-73. [DOI: 10.1177/0003319718787367] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
26 Melton PE, Zlojutro M, Kimminau K, Crawford M. Biological aging and Cox hazard analysis of mortality trends in a Mennonite community from south-central Kansas. Am J Hum Biol 2006;18:387-401. [DOI: 10.1002/ajhb.20514] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
27 Mok Y, Son DK, Yun YD, Jee SH, Samet JM. γ-Glutamyltransferase and cancer risk: The Korean cancer prevention study. Int J Cancer 2016;138:311-9. [PMID: 26111622 DOI: 10.1002/ijc.29659] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
28 Targher G, Byrne CD. Circulating Markers of Liver Function and Cardiovascular Disease Risk. Arterioscler Thromb Vasc Biol. 2015;35:2290-2296. [PMID: 25977566 DOI: 10.1161/atvbaha.115.305235] [Cited by in Crossref: 34] [Cited by in F6Publishing: 14] [Article Influence: 4.9] [Reference Citation Analysis]
29 Ndrepepa G, Kastrati A. Gamma-glutamyl transferase and cardiovascular disease. Ann Transl Med. 2016;4:481. [PMID: 28149843 DOI: 10.21037/atm.2016.12.27] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 7.5] [Reference Citation Analysis]
30 Lee SH, Kim KM, Kim KN. Combined effect of serum gamma-glutamyltransferase and uric acid on incidence of diabetes mellitus: A longitudinal study. Medicine (Baltimore) 2017;96:e6901. [PMID: 28489802 DOI: 10.1097/MD.0000000000006901] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
31 Chung HS, Lee JS, Kim JA, Roh E, Lee YB, Hong SH, Yoo HJ, Baik SH, Kim NH, Seo JA, Kim SG, Kim NH, Choi KM. γ-Glutamyltransferase Variability and the Risk of Mortality, Myocardial Infarction, and Stroke: A Nationwide Population-Based Cohort Study. J Clin Med 2019;8:E832. [PMID: 31212805 DOI: 10.3390/jcm8060832] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
32 Du G, Song Z, Zhang Q. Gamma-glutamyltransferase is associated with cardiovascular and all-cause mortality: a meta-analysis of prospective cohort studies. Prev Med. 2013;57:31-37. [PMID: 23571185 DOI: 10.1016/j.ypmed.2013.03.011] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
33 Franzini M, Corti A, Martinelli B, Del Corso A, Emdin M, Parenti GF, Glauber M, Pompella A, Paolicchi A. Gamma-glutamyltransferase activity in human atherosclerotic plaques--biochemical similarities with the circulating enzyme. Atherosclerosis. 2009;202:119-127. [PMID: 18486136 DOI: 10.1016/j.atherosclerosis.2008.03.023] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 5.9] [Reference Citation Analysis]
34 Choi HS, Kim KJ, Rhee Y, Lim SK. Serum γ-Glutamyl Transferase Is Inversely Associated with Bone Mineral Density Independently of Alcohol Consumption. Endocrinol Metab (Seoul) 2016;31:64-71. [PMID: 26676328 DOI: 10.3803/EnM.2016.31.1.64] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
35 Brenner H, Rothenbacher D, Arndt V, Schuberth S, Fraisse E, Fliedner TM. Distribution, Determinants, and Prognostic Value of γ-Glutamyltransferase for All-Cause Mortality in a Cohort of Construction Workers from Southern Germany. Preventive Medicine 1997;26:305-10. [DOI: 10.1006/pmed.1997.0144] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 2.4] [Reference Citation Analysis]
36 Sen N, Basar N, Maden O, Ozcan F, Ozlu MF, Gungor O, Turak O, Malcok O, Atak R, Demir AD, Balbay Y. Serum gamma-glutamyl transferase activity increased in patients with coronary artery ectasia. Coronary Artery Disease 2008;19:455-8. [DOI: 10.1097/mca.0b013e32830eaba1] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
37 Kim HC, Kang DR, Nam CM, Hur NW, Shim JS, Jee SH, Suh I. Elevated serum aminotransferase level as a predictor of intracerebral hemorrhage: Korea medical insurance corporation study. Stroke. 2005;36:1642-1647. [PMID: 16020763 DOI: 10.1161/01.str.0000173404.37692.9b] [Cited by in Crossref: 39] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
38 Nilssen O, Averina M, Brenn T, Brox J, Kalinin A, Archipovski V. Alcohol consumption and its relation to risk factors for cardiovascular disease in the north-west of Russia: the Arkhangelsk study. International Journal of Epidemiology 2005;34:781-8. [DOI: 10.1093/ije/dyi078] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
39 Breitling LP, Claessen H, Drath C, Arndt V, Brenner H. Gamma-glutamyltransferase, general and cause-specific mortality in 19,000 construction workers followed over 20 years. Journal of Hepatology 2011;55:594-601. [DOI: 10.1016/j.jhep.2010.12.029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
40 Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol. 2008;49:600-607. [PMID: 18672311 DOI: 10.1016/j.jhep.2008.06.012] [Cited by in Crossref: 257] [Cited by in F6Publishing: 245] [Article Influence: 18.4] [Reference Citation Analysis]
41 Song J, Yang J, Yan L, Yang J, Wen T, Li B, Zeng Y, Wu H, Wang W, Xu M, Chen Z, Wei Y, Jiang L. A new index predicts early allograft dysfunction following living donor liver transplantation: A propensity score analysis. Digestive and Liver Disease 2017;49:1225-32. [DOI: 10.1016/j.dld.2017.06.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
42 Haring R, Wallaschofski H, Nauck M, Dörr M, Baumeister SE, Völzke H. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Hepatology. 2009;50:1403-1411. [PMID: 19670414 DOI: 10.1002/hep.23135] [Cited by in Crossref: 158] [Cited by in F6Publishing: 148] [Article Influence: 12.2] [Reference Citation Analysis]
43 Qin X, Tang G, Qiu L, Xu T, Cheng X, Han S, Zhu G, Liu Y. Association between γ-glutamyltransferase and prehypertension. Mol Med Rep 2012;5:1092-8. [PMID: 22266633 DOI: 10.3892/mmr.2012.761] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Patil R, Sood GK. Non-alcoholic fatty liver disease and cardiovascular risk. World J Gastrointest Pathophysiol 2017; 8(2): 51-58 [PMID: 28573067 DOI: 10.4291/wjgp.v8.i2.51] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 59] [Article Influence: 13.0] [Reference Citation Analysis]
45 Drogan D, Weikert C, Dierkes J, Klipstein-grobusch K, Buijsse B, Möhlig M, Pfeiffer AFH, Pischon T, Spranger J, Boeing H. Plasma γ-Glutamyltransferase, Cysteinyl-Glycine, and Oxidized Low-Density Lipoprotein: A Pathway Associated With Myocardial Infarction Risk? ATVB 2010;30:2053-8. [DOI: 10.1161/atvbaha.110.209346] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
46 Kunutsor SK, Apekey TA, Seddoh D, Walley J. Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis. Int J Epidemiol. 2014;43:187-201. [PMID: 24585856 DOI: 10.1093/ije/dyt192] [Cited by in Crossref: 82] [Cited by in F6Publishing: 82] [Article Influence: 11.7] [Reference Citation Analysis]
47 Sakuta H, Suzuki T, Katayama Y, Yasuda H, Ito T. Heavy alcohol intake, homocysteine and Type 2 diabetes. Diabet Med. 2005;22:1359-1363. [PMID: 16176197 DOI: 10.1111/j.1464-5491.2005.01653.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
48 Lee DH, Ha MH, Kam S, Chun B, Lee J, Song K, Boo Y, Steffen L, Jacobs DR Jr. A strong secular trend in serum gamma-glutamyltransferase from 1996 to 2003 among South Korean men. Am J Epidemiol 2006;163:57-65. [PMID: 16293720 DOI: 10.1093/aje/kwj006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
49 Caravaca-fontán F, Azevedo L, Bayo MÁ, Gonzales-candia B, Luna E, Caravaca F. Niveles séricos elevados de gamma-glutamil transferasa y fosfatasa alcalina son predictores independientes de mortalidad en la enfermedad renal crónica estadio 4-5. Nefrología 2017;37:267-75. [DOI: 10.1016/j.nefro.2016.11.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
50 Koseoglu HI, Altunkas F, Demir O, Doruk S, Etikan I, Benli I. Serum levels of gamma-glutamyl transferase are associated with cardiovascular disease in obstructive sleep apnea syndrome. Ann Saudi Med 2013;33:584-90. [PMID: 24413863 DOI: 10.5144/0256-4947.2013.584] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
51 Claessen H, Brenner H, Drath C, Arndt V. Gamma-glutamyltransferase and disability pension: a cohort study of construction workers in Germany. Hepatology 2010;51:482-90. [PMID: 19967717 DOI: 10.1002/hep.23324] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
52 Cho YK, Kang YM, Hwang JY, Kim EH, Yang DH, Kang JW, Park JY, Lee WJ, Kim HK, Jung CH. Association between serum gamma-glutamyltransferase and the progression of coronary artery calcification. Atherosclerosis 2015;243:300-6. [PMID: 26414209 DOI: 10.1016/j.atherosclerosis.2015.09.027] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
53 Battino M, Greabu M, Totan A, Mohora M, Bullon P, Bucur A, Totan C, Tovaru S, Parlatescu I, Didilescu A, Spinu T. Oxidative stress markers in oral lichen planus. BioFactors 2008;33:301-10. [DOI: 10.1002/biof.5520330406] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
54 Hodgson JM, Ward NC, Burke V, Beilin LJ, Puddey IB. Increased lean red meat intake does not elevate markers of oxidative stress and inflammation in humans. J Nutr 2007;137:363-7. [PMID: 17237312 DOI: 10.1093/jn/137.2.363] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
55 Guessous I, Bonny O, Paccaud F, Mooser V, Waeber G, Vollenweider P, Bochud M. Serum calcium levels are associated with novel cardiometabolic risk factors in the population-based CoLaus study. PLoS One 2011;6:e18865. [PMID: 21533040 DOI: 10.1371/journal.pone.0018865] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
56 Turgut O, Tandogan I, Gurlek A. Association of γ-Glutamyltransferase with Cardiovascular Risk: A Prognostic Outlook. Archives of Medical Research 2009;40:318-20. [DOI: 10.1016/j.arcmed.2009.04.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
57 Arasteh S, Moohebati M, Avan A, Esmaeili H, Ghazizadeh H, Mahdizadeh A, Rahmani F, Mohamamdazade E, Ferns GA, Parizadeh MR, Ghayour-Mobarhan M. Serum level of gamma-glutamyl transferase as a biomarker for predicting stenosis severity in patients with coronary artery disease. Indian Heart J 2018;70:788-92. [PMID: 30580846 DOI: 10.1016/j.ihj.2017.11.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Lee D, Ha M, Kim J, Gross M, Jacobs DR. Gamma-glutamyltransferase, Alcohol, and Blood Pressure. Annals of Epidemiology 2002;12:90-6. [DOI: 10.1016/s1047-2797(01)00252-6] [Cited by in Crossref: 62] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
59 Lee D, Jacobs DR, Gross M, Steffes M. Serum γ-Glutamyltransferase Was Differently Associated with Microalbuminuria by Status of Hypertension or Diabetes: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clinical Chemistry 2005;51:1185-91. [DOI: 10.1373/clinchem.2004.045872] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 3.4] [Reference Citation Analysis]
60 Caliskan M, Erdogan D, Gullu H, Ciftci O, Yildirim I, Baycan S, Yildirir A, Muderrisoglu H. Association between serum gamma-glutamyltransferase levels and coronary microvascular function in hypertensive patients. J Hypertens 2007;25:2497-503. [PMID: 17984672 DOI: 10.1097/HJH.0b013e3282f05bf1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
61 Torino C, Mattace-Raso F, van Saase JL, Postorino M, Tripepi GL, Mallamaci F, Zoccali C, Progredire Study Group. Oxidative Stress as Estimated by Gamma-Glutamyl Transferase Levels Amplifies the Alkaline Phosphatase-Dependent Risk for Mortality in ESKD Patients on Dialysis. Oxid Med Cell Longev 2016;2016:8490643. [PMID: 27525053 DOI: 10.1155/2016/8490643] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
62 Gaziano JM, Buring JE. Alcohol intake, lipids and risks of myocardial infarction. Novartis Found Symp 1998;216:86-95; discussion 95-110. [PMID: 9949789 DOI: 10.1002/9780470515549.ch7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
63 Lee YJ, Kim JK, Lee JH, Lee HR, Kang DR, Shim JY. Association of serum gamma-glutamyltransferase with C-reactive protein levels and white blood cell count in Korean adults. Clin Chem Lab Med 2008;46:1410-5. [PMID: 18844495 DOI: 10.1515/CCLM.2008.280] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
64 Monami M, Bardini G, Lamanna C, Pala L, Cresci B, Francesconi P, Buiatti E, Rotella CM, Mannucci E. Liver enzymes and risk of diabetes and cardiovascular disease: Results of the Firenze Bagno a Ripoli (FIBAR) study. Metabolism 2008;57:387-92. [DOI: 10.1016/j.metabol.2007.10.015] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 5.4] [Reference Citation Analysis]
65 Grimm C, Hofstetter G, Aust S, Mutz-Dehbalaie I, Bruch M, Heinze G, Rahhal-Schupp J, Reinthaller A, Concin N, Polterauer S. Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer. Br J Cancer 2013;109:610-4. [PMID: 23921280 DOI: 10.1038/bjc.2013.323] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 5.7] [Reference Citation Analysis]
66 Karlson BW, Wiklund O, Hallgren P, Sjolin M, Lindqvist J, Herlitz J. Ten-year mortality amongst patients with a very small or unconfirmed acute myocardial infarction in relation to clinical history, metabolic screening and signs of myocardial ischaemia. J Intern Med 2000;247:449-56. [DOI: 10.1046/j.1365-2796.2000.00679.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
67 Ryu S, Chang Y, Kim DI, Kim WS, Suh BS. gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem. 2007;53:71-77. [PMID: 17110470 DOI: 10.1373/clinchem.2006.078980] [Cited by in Crossref: 129] [Cited by in F6Publishing: 122] [Article Influence: 8.1] [Reference Citation Analysis]
68 Benini F, Pigozzi MG, Baisini O, Romanini L, Ahmed H, Pozzi A, Ricci C, Lanzini A. Increased serum gamma-glutamyl-transpeptidase concentration is associated with nonalcoholic steatosis and not with cholestasis in patients with chronic hepatitis C. J Gastroenterol Hepatol 2007;22:1621-6. [DOI: 10.1111/j.1440-1746.2006.04733.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
69 Emdin M, Passino C, Michelassi C, Donato L, Pompella A, Paolicchi A. Additive prognostic value of gamma-glutamyltransferase in coronary artery disease. International Journal of Cardiology 2009;136:80-5. [DOI: 10.1016/j.ijcard.2008.04.030] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
70 Pisa P, Kruger A, Vorster H, Margetts B, Loots Du T. Alcohol consumption and cardiovascular disease risk in an African population in transition: the Prospective Urban and Rural Epidemiology (PURE) study. South African Journal of Clinical Nutrition 2016;23:29-37. [DOI: 10.1080/16070658.2010.11734299] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
71 Han Y, Zhang Y, Liu S, Chen G, Cao L, Xin Y. Association of LDLR rs1433099 with the Risk of NAFLD and CVD in Chinese Han Population. J Clin Transl Hepatol 2021;9:203-9. [PMID: 34007802 DOI: 10.14218/JCTH.2020.00163] [Reference Citation Analysis]
72 Benjamin EJ, Dupuis J, Larson MG, Lunetta KL, Booth SL, Govindaraju DR, Kathiresan S, Keaney JF Jr, Keyes MJ, Lin JP, Meigs JB, Robins SJ, Rong J, Schnabel R, Vita JA, Wang TJ, Wilson PW, Wolf PA, Vasan RS. Genome-wide association with select biomarker traits in the Framingham Heart Study. BMC Med Genet 2007;8 Suppl 1:S11. [PMID: 17903293 DOI: 10.1186/1471-2350-8-S1-S11] [Cited by in Crossref: 84] [Cited by in F6Publishing: 55] [Article Influence: 5.6] [Reference Citation Analysis]
73 Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation. 2005;112:2130-2137. [PMID: 16186419 DOI: 10.1161/circulationaha.105.552547] [Cited by in Crossref: 382] [Cited by in F6Publishing: 125] [Article Influence: 22.5] [Reference Citation Analysis]
74 Sakuta H, Suzuki T, Yasuda H, Ito T. Gamma-glutamyl transferase and airflow obstruction in middle-aged men. Eur J Intern Med 2005;16:348-51. [PMID: 16137549 DOI: 10.1016/j.ejim.2005.06.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
75 Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH. Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci (Lond). 2009;116:539-564. [PMID: 19243311 DOI: 10.1042/cs20080253] [Cited by in Crossref: 160] [Cited by in F6Publishing: 74] [Article Influence: 12.3] [Reference Citation Analysis]
76 Chang Y, Ryu S, Sung E, Woo HY, Oh E, Cha K, Jung E, Kim WS. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metabolism. 2008;57:569-576. [PMID: 18328362 DOI: 10.1016/j.metabol.2007.11.022] [Cited by in Crossref: 88] [Cited by in F6Publishing: 86] [Article Influence: 6.3] [Reference Citation Analysis]
77 Saki S, Saki N, Poustchi H, Malekzadeh R. Assessment of Genetic Aspects of Non-alcoholic Fatty Liver and Premature Cardiovascular Events. Middle East J Dig Dis 2020;12:65-88. [PMID: 32626560 DOI: 10.34172/mejdd.2020.166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Ndrepepa G, Xhepa E, Colleran R, Braun S, Cassese S, Fusaro M, Laugwitz K, Kastrati A. Gamma-glutamyl transferase and atrial fibrillation in patients with coronary artery disease. Clinica Chimica Acta 2017;465:17-21. [DOI: 10.1016/j.cca.2016.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
79 Lee DH, Gross MD, Jacobs DR. Association of serum carotenoids and tocopherols with gamma-glutamyltransferase: the Cardiovascular Risk Development in Young Adults (CARDIA) Study. Clin Chem. 2004;50:582-588. [PMID: 14726472 DOI: 10.1373/clinchem.2003.028852] [Cited by in Crossref: 76] [Cited by in F6Publishing: 74] [Article Influence: 4.2] [Reference Citation Analysis]
80 Meisinger C, Döring A, Schneider A, Löwel H; KORA Study Group. Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis 2006;189:297-302. [PMID: 16483579 DOI: 10.1016/j.atherosclerosis.2006.01.010] [Cited by in Crossref: 99] [Cited by in F6Publishing: 87] [Article Influence: 6.2] [Reference Citation Analysis]
81 Simão ANC, Dichi JB, Barbosa DS, Cecchini R, Dichi I. Influence of uric acid and γ-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome. Nutrition 2008;24:675-81. [DOI: 10.1016/j.nut.2008.03.021] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
82 Poikolainen K. Effectiveness of Brief Interventions to Reduce Alcohol Intake in Primary Health Care Populations: A Meta-analysis. Preventive Medicine 1999;28:503-9. [DOI: 10.1006/pmed.1999.0467] [Cited by in Crossref: 130] [Cited by in F6Publishing: 105] [Article Influence: 5.7] [Reference Citation Analysis]
83 Giral P, Jacob N, Dourmap C, Hansel B, Carrié A, Bruckert E, Girerd X, Chapman MJ. Elevated Gamma-Glutamyltransferase Activity and Perturbed Thiol Profile Are Associated With Features of Metabolic Syndrome. ATVB 2008;28:587-93. [DOI: 10.1161/atvbaha.107.157891] [Cited by in Crossref: 42] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
84 Miller PM, Anton RF, Egan BM, Basile J, Nguyen SA. Excessive alcohol consumption and hypertension: clinical implications of current research. J Clin Hypertens (Greenwich). 2005;7:346-351. [PMID: 16088298 DOI: 10.1111/j.1524-6175.2004.04463.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
85 Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 2005;112:2078-80. [PMID: 16203922 DOI: 10.1161/CIRCULATIONAHA.105.571919] [Cited by in Crossref: 215] [Cited by in F6Publishing: 79] [Article Influence: 13.4] [Reference Citation Analysis]
86 Shabbir S, Khan DA, Khan FA, Elahi MM, Matata BM. Serum gamma glutamyl transferase: a novel biomarker for screening of premature coronary artery disease. Cardiovasc Revasc Med. 2011;12:367-374. [PMID: 21454140 DOI: 10.1016/j.carrev.2011.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
87 Mahady SE, Wong G, Turner RM, Mitchell P, Macaskill P, Craig JC, George J. Elevated Liver Enzymes and Mortality in Older Individuals: A Prospective Cohort Study. Journal of Clinical Gastroenterology 2017;51:439-45. [DOI: 10.1097/mcg.0000000000000622] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
88 Nuti M, Spontoni P, Grigoratos C, Dell'Omo G, Balbarini A, Pedrinelli R. Lack of a relationship between circulating gamma-glutamyltransferase levels and carotid intima media thickness in hypertensive and diabetic patients. Vasc Health Risk Manag 2012;8:275-81. [PMID: 22661894 DOI: 10.2147/VHRM.S30747] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
89 Spoto B, D'Arrigo G, Tripepi G, Bolignano D, Zoccali C. Serum gamma-glutamyltransferase, oxidized LDL and mortality in the elderly. Aging Clin Exp Res 2021;33:1393-7. [PMID: 31677124 DOI: 10.1007/s40520-019-01391-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
90 Poelzl G, Ess M, Mussner-seeber C, Pachinger O, Frick M, Ulmer H. Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance: LIVER DYSFUNCTION IN CHRONIC HEART FAILURE. European Journal of Clinical Investigation 2012;42:153-63. [DOI: 10.1111/j.1365-2362.2011.02573.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 73] [Article Influence: 7.8] [Reference Citation Analysis]
91 Shin JY, Hwang JH, Jeong JY, Kim SH, Moon JD, Roh SC, Kim YW, Kim Y, Leem JH, Ju YS, Hong YS, Ha EH, Lee YH, Lee DH, Kim DH. [The association of central obesity with type 2 diabetes among Koreans according to the serum gamma-glutamyltransferase level: Korean genome and epidemiology study]. J Prev Med Public Health 2009;42:386-91. [PMID: 20009485 DOI: 10.3961/jpmph.2009.42.6.386] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
92 Stojakovic T, Scharnagl H, Trauner M, Pieske B, Wellnitz B, Seelhorst U, Schilling D, Winkelmann BR, Boehm BO, März W. Serum gamma-glutamyl transferase and mortality in persons undergoing coronary angiography—The Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis 2010;208:564-71. [DOI: 10.1016/j.atherosclerosis.2009.07.026] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
93 Aimo A, Chiappino S, Paolicchi A, Della Latta D, Martini N, Clemente A, Musetti V, Masotti S, Panichella G, Piagneri V, Storti S, Monteleone A, Passino C, Chiappino D, Franzini M, Emdin M. Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population. Eur J Prev Cardiol 2021:zwab215. [PMID: 34928344 DOI: 10.1093/eurjpc/zwab215] [Reference Citation Analysis]
94 Higashikawa A, Suwazono Y, Okubo Y, Uetani M, Kobayashi E, Kido T, Nogawa K. Association of Working Conditions and Lifestyle with Increased Serum Gamma-Glutamyltransferase: A Follow-up Study. Archives of Medical Research 2005;36:567-73. [DOI: 10.1016/j.arcmed.2005.03.027] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
95 Shin W, Jung D, Shim J, Lee H. The association between non-alcoholic hepatic steatosis and mean platelet volume in an obese Korean population. Platelets 2011;22:442-6. [DOI: 10.3109/09537104.2010.540049] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
96 Kang YH, Min HK, Son SM, Kim IJ, Kim YK. The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults. Diabetes Research and Clinical Practice 2007;77:306-13. [DOI: 10.1016/j.diabres.2006.11.009] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
97 Targher G. Non-alcoholic fatty liver disease as a determinant of cardiovascular disease. Atherosclerosis 2007;190:18-9; author reply 20-1. [PMID: 16828776 DOI: 10.1016/j.atherosclerosis.2006.06.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
98 Emdin M, Passino C, Pompella A, Paolicchi A. Serum gamma-glutamyl transpeptidase: A prognostic marker in cardiovascular diseases. BioFactors 2003;17:199-205. [DOI: 10.1002/biof.5520170119] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
99 Turgut O, Yilmaz A, Yalta K, Karadas F, Birhan Yilmaz M. gamma-Glutamyltransferase is a promising biomarker for cardiovascular risk. Med Hypotheses. 2006;67:1060-1064. [PMID: 16891060 DOI: 10.1016/j.mehy.2006.04.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
100 Franzini M, Paolicchi A, Fornaciari I, Ottaviano V, Fierabracci V, Maltinti M, Ripoli A, Zyw L, Scatena F, Passino C. Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. Clin Chem Lab Med. 2010;48:713-717. [PMID: 20158443 DOI: 10.1515/cclm.2010.125] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
101 Onat A, Can G, örnek E, Çiçek G, Ayhan E, Doğan Y. Serum γ-Glutamyltransferase: Independent Predictor of Risk of Diabetes, Hypertension, Metabolic Syndrome, and Coronary Disease. Obesity 2012;20:842-8. [DOI: 10.1038/oby.2011.136] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
102 Lee DH, Blomhoff R, Jacobs DR. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res. 2004;38:535-539. [PMID: 15346644 DOI: 10.1080/10715760410001694026] [Cited by in Crossref: 413] [Cited by in F6Publishing: 376] [Article Influence: 22.9] [Reference Citation Analysis]
103 Kasapoglu B, Turkay C, Yalcın KS, Carlioglu A, Koktener A. Role of γ-glutamyl transferase levels in prediction of high cardiovascular risk among patients with non-alcoholic fatty liver disease. Indian J Med Res 2016;143:30-6. [PMID: 26997011 DOI: 10.4103/0971-5916.178585] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
104 Franzini M, Bramanti E, Ottaviano V, Ghiri E, Scatena F, Barsacchi R, Pompella A, Donato L, Emdin M, Paolicchi A. A high performance gel filtration chromatography method for γ-glutamyltransferase fraction analysis. Analytical Biochemistry 2008;374:1-6. [DOI: 10.1016/j.ab.2007.10.025] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
105 Ahmed MH, Byrne CD. Non-Alcoholic Fatty Liver Disease. In: Byrne CD, Wild SH, editors. The Metabolic Syndrome. Oxford: Wiley-Blackwell; 2011. pp. 245-77. [DOI: 10.1002/9781444347319.ch15] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
106 Jimba S, Nakagami T, Oya J, Wasada T, Endo Y, Iwamoto Y. Increase in gamma-glutamyltransferase level and development of established cardiovascular risk factors and diabetes in Japanese adults. Metab Syndr Relat Disord 2009;7:411-8. [PMID: 19419267 DOI: 10.1089/met.2008.0082] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
107 Kang JH, Cho KI, Kim SM, Lee JY, Kim JJ, Goo JJ, Kim KN, Jhi JH, Kim DJ, Lee HG. Relationship between Nonalcoholic Fatty Liver Disease and Carotid Artery Atherosclerosis Beyond Metabolic Disorders in Non-Diabetic Patients. J Cardiovasc Ultrasound. 2012;20:126-133. [PMID: 23185655 DOI: 10.4250/jcu.2012.20.3.126] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
108 Emdin M, Passino C, Franzini M, Paolicchi A, Pompella A. gamma-glutamyltransferase and pathogenesis of cardiovascular diseases. Future Cardiol. 2007;3:263-270. [PMID: 19804218 DOI: 10.2217/14796678.3.3.263] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
109 Ho C, Tsao Y, Chen J, Chang K, Tsai Y, Lin J, Chang S. Gamma-glutamyl transpeptidase and the metabolic syndrome in a Taiwanese aboriginal population. Int J Diabetes Dev Ctries 2013;33:147-54. [DOI: 10.1007/s13410-013-0127-1] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
110 Poelzl G, Eberl C, Achrainer H, Doerler J, Pachinger O, Frick M, Ulmer H. Prevalence and Prognostic Significance of Elevated γ-Glutamyltransferase in Chronic Heart Failure. Circ: Heart Failure 2009;2:294-302. [DOI: 10.1161/circheartfailure.108.826735] [Cited by in Crossref: 47] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
111 Ess M, Mussner-Seeber C, Mariacher S, Lorsbach-Koehler A, Pachinger O, Frick M, Ulmer H, Poelzl G. γ-Glutamyltransferase rather than total bilirubin predicts outcome in chronic heart failure. J Card Fail 2011;17:577-84. [PMID: 21703530 DOI: 10.1016/j.cardfail.2011.02.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
112 Cheung BM, Ong KL, Tso AW, Cherny SS, Sham PC, Lam TH, Lam KS. Gamma-glutamyl transferase level predicts the development of hypertension in Hong Kong Chinese. Clin Chim Acta 2011;412:1326-31. [PMID: 21466796 DOI: 10.1016/j.cca.2011.03.030] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
113 Kim JA, Kim SM, Yoon D. The relationship between γ-glutamyltransferase and adiponectin in nonalcoholic women. Metabolism 2007;56:578-82. [DOI: 10.1016/j.metabol.2006.12.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
114 Ahmed MH, Barakat S, Almobarak AO. Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists? J Obes. 2012;2012:483135. [PMID: 23320150 DOI: 10.1155/2012/483135] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 4.6] [Reference Citation Analysis]
115 Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001;38:263-355. [PMID: 11563810 DOI: 10.1080/20014091084227] [Cited by in Crossref: 635] [Cited by in F6Publishing: 584] [Article Influence: 31.8] [Reference Citation Analysis]
116 Stranges S, Trevisan M, Dorn JM, Dmochowski J, Donahue RP. Body fat distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study. Hypertension. 2005;46:1186-1193. [PMID: 16203871 DOI: 10.1161/01.hyp.0000185688.81320.4d] [Cited by in Crossref: 77] [Cited by in F6Publishing: 42] [Article Influence: 4.5] [Reference Citation Analysis]
117 Pompella A, Emdin M, Passino C, Paolicchi A. The significance of serum gamma-glutamyltransferase in cardiovascular diseases. Clin Chem Lab Med 2004;42:1085-91. [PMID: 15552264 DOI: 10.1515/CCLM.2004.224] [Cited by in Crossref: 62] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
118 Demircan S, Yazici M, Durna K, Kilicaslan F, Demir S, Pinar M, Gulel O. The importance of gamma-glutamyltransferase activity in patients with coronary artery disease. Clin Cardiol 2009;32:220-5. [PMID: 19353699 DOI: 10.1002/clc.20345] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
119 Ortakoyluoglu A, Boz B, Dizdar OS, Avcı D, Cetinkaya A, Baspınar O. The association of serum gamma-glutamyl transpeptidase level and other laboratory parameters with blood pressure in hypertensive patients under ambulatory blood pressure monitoring. Ther Clin Risk Manag 2016;12:1395-401. [PMID: 27660457 DOI: 10.2147/TCRM.S116603] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
120 Strasak AM, Kelleher CC, Klenk J, Brant LJ, Ruttmann E, Rapp K, Concin H, Diem G, Pfeiffer KP, Ulmer H; Vorarlberg Health Monitoring and Promotion Program Study Group. Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality: a prospective population-based study in 76,113 Austrian adults. Arterioscler Thromb Vasc Biol. 2008;28:1857-1865. [PMID: 18617645 DOI: 10.1161/atvbaha.108.170597] [Cited by in Crossref: 75] [Cited by in F6Publishing: 32] [Article Influence: 5.4] [Reference Citation Analysis]
121 Eroglu S, Sade LE, Polat E, Bozbas H, Ulus T, Muderrisoglu H. Association Between Serum Gamma-Glutamyltransferase Activity and Carotid Intima-Media Thickness. Angiology 2011;62:107-10. [DOI: 10.1177/0003319710386471] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
122 Kanbay A, Kaya E, Buyukoglan H, Ozdogan N, Kaya MG, Oymak FS, Gulmez I, Demir R, Kokturk O. Serum gamma-glutamyl transferase activity is an independent predictor for cardiovascular disease in Obstructive Sleep Apnea Syndrome. Respiratory Medicine 2011;105:637-42. [DOI: 10.1016/j.rmed.2010.12.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
123 Sluik D, Beulens JW, Weikert C, van Dieren S, Spijkerman AM, van der A DL, Fritsche A, Joost HG, Boeing H, Nöthlings U. Gamma-glutamyltransferase, cardiovascular disease and mortality in individuals with diabetes mellitus. Diabetes Metab Res Rev 2012;28:284-8. [PMID: 22144398 DOI: 10.1002/dmrr.2261] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
124 Wannamethee SG, Lennon L, Shaper AG. The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes. Atherosclerosis. 2008;201:168-175. [PMID: 18378241 DOI: 10.1016/j.atherosclerosis.2008.01.019] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 5.5] [Reference Citation Analysis]
125 Yuksel UC, Celik T, Celik M, Bugan B, Iyisoy A, Yaman H. High admission levels of γ-glutamyltransferase predict poor myocardial perfusion after primary percutaneous intervention. Clinics (Sao Paulo) 2011;66:1729-34. [PMID: 22012044 DOI: 10.1590/s1807-59322011001000010] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
126 Fernández-Real JM, López-Bermejo A, Broch M, Vendrell J, Richart C, Ricart W. Circulating soluble CD14 monocyte receptor is associated with increased alanine aminotransferase. Clin Chem 2004;50:1456-8. [PMID: 15277359 DOI: 10.1373/clinchem.2003.030015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
127 Ahmed MH, Abu EO, Byrne CD. Non-Alcoholic Fatty Liver Disease (NAFLD): new challenge for general practitioners and important burden for health authorities? Prim Care Diabetes. 2010;4:129-137. [PMID: 20299294 DOI: 10.1016/j.pcd.2010.02.004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
128 Breitling L, Grandi N, Hahmann H, Wüsten B, Rothenbacher D, Brenner H. Gamma-glutamyltransferase and prognosis in patients with stable coronary heart disease followed over 8 years. Atherosclerosis 2010;210:649-55. [DOI: 10.1016/j.atherosclerosis.2009.12.037] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
129 Zorlu A, Yucel H, Bektasoglu G, Turkdogan KA, Eryigit U, Sarikaya S, Ege MR, Tandogan I, Yilmaz MB. Increased γ-glutamyl transferase levels predict early mortality in patients with acute pulmonary embolism. Am J Emerg Med 2012;30:908-15. [PMID: 22386346 DOI: 10.1016/j.ajem.2011.12.040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
130 Aberkane H, Stoltz JF, Galteau MM, Wellman M. Erythrocytes as targets for gamma-glutamyltranspeptidase initiated pro-oxidant reaction. Eur J Haematol 2002;68:262-71. [PMID: 12144532 DOI: 10.1034/j.1600-0609.2002.01636.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
131 Turgut O, Yilmaz MB, Yalta K, Tandogan I. Gamma-glutamyltransferase as a useful predictor for cardiovascular risk: clinical and epidemiological perspectives. Atherosclerosis 2009;202:348-9. [PMID: 18571178 DOI: 10.1016/j.atherosclerosis.2008.05.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
132 Hozawa A, Okamura T, Kadowaki T, Murakami Y, Nakamura K, Hayakawa T, Kita Y, Nakamura Y, Okayama A, Ueshima H; NIPPON DATA90 Research Group. gamma-Glutamyltransferase predicts cardiovascular death among Japanese women. Atherosclerosis. 2007;194:498-504. [PMID: 17034795 DOI: 10.1016/j.atherosclerosis.2006.08.058] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
133 Saijo Y, Utsugi M, Yoshioka E, Horikawa N, Sato T, Gong Y, Kishi R. The relationship of gamma-glutamyltransferase to C-reactive protein and arterial stiffness. Nutr Metab Cardiovasc Dis 2008;18:211-9. [PMID: 17412574 DOI: 10.1016/j.numecd.2006.10.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
134 Whitfield JB, Zhu G, Nestler JE, Heath AC, Martin NG. Genetic Covariation between Serum γ-Glutamyltransferase Activity and Cardiovascular Risk Factors. Clinical Chemistry 2002;48:1426-31. [DOI: 10.1093/clinchem/48.9.1426] [Cited by in Crossref: 54] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
135 Danikiewicz A, Hudzik B, Nowak J, Kowalska J, Zieleń-Zynek I, Szkodzinski J, Naung Tun H, Zubelewicz-Szkodzinska B. Serum Gamma Glutamyltransferase Is Associated with 25-Hydroxyvitamin D Status in Elderly Patients with Stable Coronary Artery Disease. Int J Environ Res Public Health 2020;17:E8980. [PMID: 33276664 DOI: 10.3390/ijerph17238980] [Reference Citation Analysis]
136 Strasak AM, Rapp K, Brant LJ, Hilbe W, Gregory M, Oberaigner W, Ruttmann E, Concin H, Diem G, Pfeiffer KP, Ulmer H; VHM&PP Study Group. Association of gamma-glutamyltransferase and risk of cancer incidence in men: a prospective study. Cancer Res. 2008;68:3970-3977. [PMID: 18483283 DOI: 10.1158/0008-5472.can-07-6686] [Cited by in Crossref: 80] [Cited by in F6Publishing: 39] [Article Influence: 5.7] [Reference Citation Analysis]
137 Mason JE, Starke RD, Van Kirk JE. Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Prev Cardiol. 2010;13:36-41. [PMID: 20021625 DOI: 10.1111/j.1751-7141.2009.00054.x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 105] [Article Influence: 10.4] [Reference Citation Analysis]
138 Middelberg RPS, Medland SE, Martin NG, Whitfield JB. A Longitudinal Genetic Study of Uric Acid and Liver Enzymes in Adolescent Twins. Twin Res Hum Genet 2007;10:757-64. [DOI: 10.1375/twin.10.5.757] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
139 Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis. 2007;191:235-240. [PMID: 16970951 DOI: 10.1016/j.atherosclerosis.2006.08.021] [Cited by in Crossref: 355] [Cited by in F6Publishing: 328] [Article Influence: 22.2] [Reference Citation Analysis]
140 Kim KN, Kim KM, Lee DJ, Joo NS. Serum gamma-glutamyltransferase concentration correlates with Framingham risk score in Koreans. J Korean Med Sci 2011;26:1305-9. [PMID: 22022182 DOI: 10.3346/jkms.2011.26.10.1305] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
141 Karlson BW, Lindqvist J, Sjölin M, Caidahl K, Herlitz J. Which factors determine the long-term outcome among patients with a very small or unconfirmed AMI. International Journal of Cardiology 2001;78:265-75. [DOI: 10.1016/s0167-5273(01)00383-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
142 Jo SK, Lee WY, Rhee EJ, Won JC, Jung CH, Park CY, Oh KW, Park SW, Kim SW. Serum gamma-glutamyl transferase activity predicts future development of metabolic syndrome defined by 2 different criteria. Clin Chim Acta. 2009;403:234-240. [PMID: 19332046 DOI: 10.1016/j.cca.2009.03.035] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
143 Yavuz BB, Yavuz B, Halil M, Cankurtaran M, Ulger Z, Cankurtaran ES, Aytemir K, Ariogul S. Serum elevated gamma glutamyltransferase levels may be a marker for oxidative stress in Alzheimer's disease. Int Psychogeriatr 2008;20:815-23. [PMID: 18416873 DOI: 10.1017/S1041610208006790] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
144 Steinvil A, Shapira I, Ben-Bassat OK, Cohen M, Vered Y, Berliner S, Rogowski O. The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome. Cardiovasc Diabetol 2010;9:30. [PMID: 20633271 DOI: 10.1186/1475-2840-9-30] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
145 Zureik M, Liard R, Kauffmann F, Henry C, Neukirch F. Alcohol consumption, gamma-glutamyl transpeptidase (GGT), and pulmonary function: a cross-sectional and longitudinal study in working men. Alcohol Clin Exp Res 1996;20:1507-11. [PMID: 8986195 DOI: 10.1111/j.1530-0277.1996.tb01691.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
146 Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor D. Gamma-Glutamyltransferase Is Associated With Incident Vascular Events Independently of Alcohol Intake: Analysis of the British Women’s Heart and Health Study and Meta-Analysis. ATVB 2007;27:2729-35. [DOI: 10.1161/atvbaha.107.152298] [Cited by in Crossref: 197] [Cited by in F6Publishing: 81] [Article Influence: 13.1] [Reference Citation Analysis]
147 Conigrave KM, Davies P, Haber P, Whitfield JB. Traditional markers of excessive alcohol use. Addiction. 2003;98 Suppl 2:31-43. [PMID: 14984240 DOI: 10.1046/j.1359-6357.2003.00581.x] [Cited by in Crossref: 179] [Cited by in F6Publishing: 148] [Article Influence: 9.9] [Reference Citation Analysis]
148 Lazzeri C, Valente S, Tarquini R, Chiostri M, Picariello C, Gensini GF. The prognostic role of gamma-glutamyltransferase activity in non-diabetic ST-elevation myocardial infarction. Intern Emerg Med 2011;6:213-9. [DOI: 10.1007/s11739-010-0464-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
149 Targher G. Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer - a narrative review. Clin Chem Lab Med. 2010;48:147-157. [PMID: 19943812 DOI: 10.1515/cclm.2010.031] [Cited by in Crossref: 67] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
150 Meisinger C, Lowel H, Heier M, Schneider A, Thorand B; FOR THE KORA STUDY GROUP. Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population. J Intern Med 2005;258:527-35. [DOI: 10.1111/j.1365-2796.2005.01572.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 4.4] [Reference Citation Analysis]
151 Korkmaz O, Yucel H, Zorlu A, Berkan O, Kaya H, Goksel S, Beton O, Yilmaz MB. Elevated gamma glutamyl transferase levels are associated with the location of acute pulmonary embolism. Cross-sectional evaluation in hospital setting. Sao Paulo Med J 2015;133:488-94. [DOI: 10.1590/1516-3180.2015.00131806] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
152 Ulus T, Yildirir A, Sade LE, Temiz A, Polat E, Bozbaş H, Aydinalp A, Eroğlu S, Ozin B, Müderrisoğlu H. Serum gamma-glutamyl transferase activity: new high-risk criteria in acute coronary syndrome patients? Coron Artery Dis 2008;19:489-95. [PMID: 18923245 DOI: 10.1097/MCA.0b013e32830eab8c] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
153 Cakir E, Ozkaya E, Korkmaz V, Goktas I, Kucukozkan T. Comparison of the effects of surgical and natural menopause on epicardial fat thickness and γ-glutamyltransferase level. Menopause 2011;18:901-5. [DOI: 10.1097/gme.0b013e31820ca95e] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
154 Emiroglu MY, Esen ÖB, Bulut M, Karapinar H, Kaya Z, Akcakoyun M, Kargin R, Aung SM, Alızade E, Pala S, Esen AM. GGT levels in type II diabetic patients with acute coronary syndrome (does diabetes have any effect on GGT levels in acute coronary syndrome?). Acta Diabetol 2013;50:21-5. [DOI: 10.1007/s00592-010-0208-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
155 Park SG, Lee YJ, Ham JO, Jang EC, Kim SW, Park H. Association between long working hours and serum gamma-glutamyltransferase levels in female workers: data from the fifth Korean National Health and Nutrition Examination Survey (2010-2011). Ann Occup Environ Med 2014;26:40. [PMID: 25452851 DOI: 10.1186/s40557-014-0040-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
156 Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D’Agostino RB, Vasan RS. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2007;27:127-133. [PMID: 17095717 DOI: 10.1161/01.atv.0000251993.20372.40] [Cited by in Crossref: 355] [Cited by in F6Publishing: 132] [Article Influence: 22.2] [Reference Citation Analysis]
157 Rector RS, Thyfault JP, Wei Y, Ibdah JA. Non-alcoholic fatty liver disease and the metabolic syndrome: An update. World J Gastroenterol 2008; 14(2): 185-192 [PMID: 18186553 DOI: 10.3748/wjg.14.185] [Cited by in CrossRef: 198] [Cited by in F6Publishing: 193] [Article Influence: 14.1] [Reference Citation Analysis]
158 Wannamethee SG, Whincup PH, Shaper AG, Lennon L, Sattar N. Γ-glutamyltransferase, hepatic enzymes, and risk of incident heart failure in older men. Arterioscler Thromb Vasc Biol. 2012;32:830-835. [PMID: 22223732 DOI: 10.1161/atvbaha.111.240457] [Cited by in Crossref: 39] [Cited by in F6Publishing: 20] [Article Influence: 3.9] [Reference Citation Analysis]
159 Lim JS, Yang JH, Chun BY, Kam S, Jacobs DR, Lee DH. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress? Free Radic Biol Med. 2004;37:1018-1023. [PMID: 15336318 DOI: 10.1016/j.freeradbiomed.2004.06.032] [Cited by in Crossref: 133] [Cited by in F6Publishing: 120] [Article Influence: 7.8] [Reference Citation Analysis]
160 Chan WK, Tan AT, Vethakkan SR, Tah PC, Vijayananthan A, Goh KL. Ultrasonography-diagnosed non-alcoholic fatty liver disease is not associated with prevalent ischemic heart disease among diabetics in a multiracial Asian hospital clinic population. Clin Res Hepatol Gastroenterol. 2014;38:284-291. [PMID: 24736032 DOI: 10.1016/j.clinre.2014.02.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
161 Ndrepepa G, Colleran R, Luttert A, Braun S, Cassese S, Kufner S, Hieber J, Fusaro M, Laugwitz KL, Schunkert H, Kastrati A. Prognostic value of gamma-glutamyl transferase in patients with diabetes mellitus and coronary artery disease. Clin Biochem 2016;49:1127-32. [PMID: 27220059 DOI: 10.1016/j.clinbiochem.2016.05.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
162 Long Y, Zeng F, Shi J, Tian H, Chen T. Gamma-glutamyltransferase predicts increased risk of mortality: a systematic review and meta-analysis of prospective observational studies. Free Radic Res. 2014;48:716-728. [PMID: 24684379 DOI: 10.3109/10715762.2014.902055] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
163 Yang W, Kim CK, Kim DY, Jeong H, Lee S. Gamma-glutamyl transferase predicts future stroke: A Korean nationwide study: GGT Predicts Future Stroke. Ann Neurol 2018;83:375-86. [DOI: 10.1002/ana.25158] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
164 Yokoyama H, Moriya S, Homma Y, Ogawa T. Association between gamma-glutamyl transpeptidase activity and status of disorders constituting insulin resistance syndrome. Alcohol Clin Exp Res 2003;27:22S-5S. [PMID: 12960502 DOI: 10.1097/01.ALC.0000078608.22813.D9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
165 Kim YG, Park GM, Lee SB, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, Lee SW, Kim YH. Association of gamma-glutamyl transferase with subclinical coronary atherosclerosis and cardiac outcomes in non-alcoholics. Sci Rep 2020;10:17994. [PMID: 33093619 DOI: 10.1038/s41598-020-75078-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
166 Bulusu S, Sharma M. What does serum γ-glutamyltransferase tell us as a cardiometabolic risk marker? Ann Clin Biochem 2016;53:312-32. [PMID: 26139450 DOI: 10.1177/0004563215597010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
167 Bhatia LS, Curzen NP, Calder PC, Byrne CD. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J. 2012;33:1190-1200. [PMID: 22408036 DOI: 10.1093/eurheartj/ehr453] [Cited by in Crossref: 267] [Cited by in F6Publishing: 247] [Article Influence: 26.7] [Reference Citation Analysis]
168 Brea A, Puzo J. Non-alcoholic fatty liver disease and cardiovascular risk. Int J Cardiol. 2013;167:1109-1117. [PMID: 23141876 DOI: 10.1016/j.ijcard.2012.09.085] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 5.5] [Reference Citation Analysis]
169 Rantala AO, Lilja M, Kauma H, Savolainen MJ, Reunanen A, Kesäniemi YA. Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med. 2000;248:230-238. [PMID: 10971790 DOI: 10.1046/j.1365-2796.2000.00723.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 80] [Article Influence: 4.3] [Reference Citation Analysis]
170 Lee DJ, Choi JS, Kim KM, Joo NS, Lee SH, Kim KN. Combined effect of serum gamma-glutamyltransferase and uric acid on Framingham risk score. Arch Med Res 2014;45:337-42. [PMID: 24813308 DOI: 10.1016/j.arcmed.2014.04.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
171 Sakuta H, Suzuki T, Ito T. Serum γ-glutamyl transferase is associated with plasma total homocysteine in Japanese patients with type 2 diabetes. Acta Diabetol 2007;44:177-80. [DOI: 10.1007/s00592-007-0001-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
172 Alexander KS, Zakai NA, Lidofsky SD, Callas PW, Judd SE, Tracy RP, Cushman M. Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort. PLoS One. 2018;13:e0194153. [PMID: 29529073 DOI: 10.1371/journal.pone.0194153] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
173 Bozkus F, Dikmen N, Demir LS. Gamma-glutamyl transferase activity as a predictive marker for severity of obstructive sleep apnea syndrome and concomitant hypertension. Clin Respir J 2018;12:1964-73. [PMID: 29330970 DOI: 10.1111/crj.12765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
174 Fraser A, Thinggaard M, Christensen K, Lawlor DA. Alanine aminotransferase, gamma-glutamyltransferase (GGT) and all-cause mortality: results from a population-based Danish twins study alanine aminotransferase, GGT and mortality in elderly twins. Liver Int 2009;29:1494-9. [PMID: 19686309 DOI: 10.1111/j.1478-3231.2009.02090.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
175 Lim J, Lee D, Park J, Jin S, Jacobs DR. A Strong Interaction between Serum γ-Glutamyltransferase and Obesity on the Risk of Prevalent Type 2 Diabetes: Results from the Third National Health and Nutrition Examination Survey. Clinical Chemistry 2007;53:1092-8. [DOI: 10.1373/clinchem.2006.079814] [Cited by in Crossref: 64] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
176 Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, Steffes M. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003;49:1358-66. [PMID: 12881453 DOI: 10.1373/49.8.1358] [Cited by in Crossref: 309] [Cited by in F6Publishing: 272] [Article Influence: 16.3] [Reference Citation Analysis]
177 Oni ET, Figueredo V, Aneni E, Veladar E, McEvoy JW, Blaha MJ, Blumenthal RS, Conceicao RD, Carvalho JAM, Santos RD, Nasir K. Non-Alcoholic Fatty Liver Disease Modifies Serum Gamma-Glutamyl Transferase in Cigarette Smokers. J Clin Med Res 2020;12:472-82. [PMID: 32849935 DOI: 10.14740/jocmr3932] [Reference Citation Analysis]
178 Godsland IF, Johnston DG. Co-associations between insulin sensitivity and measures of liver function, subclinical inflammation, and hematology. Metabolism 2008;57:1190-7. [PMID: 18702943 DOI: 10.1016/j.metabol.2008.04.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
179 Acikgoz N, Ermiş N, Yağmur J, Cansel M, Karincaoğlu Y, Ataş H, Cuglan B, Barutcu İ, Pekdemir H, Özdemir R. Elevated Oxidative Stress Markers and its Relationship With Endothelial Dysfunction in Behçet Disease. Angiology 2011;62:296-300. [DOI: 10.1177/0003319710382417] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
180 Kim NH, Park J, Kim SH, Kim YH, Kim DH, Cho GY, Baik I, Lim HE, Kim EJ, Na JO. Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population. Heart. 2014;100:938-943. [PMID: 24721975 DOI: 10.1136/heartjnl-2013-305099] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 6.3] [Reference Citation Analysis]
181 Beulens JW, van den Berg R, Kok FJ, Helander A, Vermunt SH, Hendriks HF. Moderate alcohol consumption and lipoprotein-associated phospholipase A2 activity. Nutrition, Metabolism and Cardiovascular Diseases 2008;18:539-44. [DOI: 10.1016/j.numecd.2007.07.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
182 Hwang AC, Lin YC, Liu PT, Kao YM, Chen JD. Synergistic effect of gamma glutamyltransferase and obesity on metabolic syndrome, independent of hepatic steatosis. Ann Epidemiol 2012;22:876-80. [PMID: 23110960 DOI: 10.1016/j.annepidem.2012.09.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
183 Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison S, Sanyal AJ; REGENERATE Study Investigators. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet. 2019;394:2184-2196. [PMID: 31813633 DOI: 10.1016/s0140-6736(19)33041-7] [Cited by in Crossref: 296] [Cited by in F6Publishing: 151] [Article Influence: 98.7] [Reference Citation Analysis]
184 Ndrepepa G, Colleran R, Kastrati A. Gamma-glutamyl transferase and the risk of atherosclerosis and coronary heart disease. Clinica Chimica Acta 2018;476:130-8. [DOI: 10.1016/j.cca.2017.11.026] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 11.0] [Reference Citation Analysis]
185 Lee D, Steffen LM, Jacobs DR. Association between serum γ-glutamyltransferase and dietary factors: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. The American Journal of Clinical Nutrition 2004;79:600-5. [DOI: 10.1093/ajcn/79.4.600] [Cited by in Crossref: 85] [Cited by in F6Publishing: 68] [Article Influence: 4.7] [Reference Citation Analysis]
186 Ali SS, Oni ET, Blaha MJ, Veledar E, Feiz HR, Feldman T, Agatston AS, Blumenthal RS, Conceicao RD, Carvalho JA, Santos RD, Nasir K. Elevated gamma-glutamyl transferase is associated with subclinical inflammation independent of cardiometabolic risk factors in an asymptomatic population: a cross-sectional study. Nutr Metab (Lond) 2016;13:37. [PMID: 27195017 DOI: 10.1186/s12986-016-0097-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
187 Lee DH, Jacobs DR. Association between serum gamma-glutamyltransferase and C-reactive protein. Atherosclerosis. 2005;178:327-330. [PMID: 15694941 DOI: 10.1016/j.atherosclerosis.2004.08.027] [Cited by in Crossref: 128] [Cited by in F6Publishing: 109] [Article Influence: 7.5] [Reference Citation Analysis]
188 Ghatge M, Sharma A, Vangala RK. Association of γ-glutamyl transferase with premature coronary artery disease. Biomed Rep 2016;4:307-12. [PMID: 26998267 DOI: 10.3892/br.2016.576] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
189 Bidel S, Silventoinen K, Hu G, Lee DH, Kaprio J, Tuomilehto J. Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes. Eur J Clin Nutr 2008;62:178-85. [PMID: 17342160 DOI: 10.1038/sj.ejcn.1602712] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
190 Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia. 2008;51:1947-1953. [PMID: 18762907 DOI: 10.1007/s00125-008-1135-4] [Cited by in Crossref: 256] [Cited by in F6Publishing: 243] [Article Influence: 18.3] [Reference Citation Analysis]
191 Bian LQ, Zhang ZY, Kim SJ, Zhou CC, Choi YH. Gamma glutamyltransferase as a novel marker of coronary artery calcification in women. J Cardiovasc Med (Hagerstown) 2012;13:684-90. [PMID: 22801074 DOI: 10.2459/JCM.0b013e328356a432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
192 Spoto B, Mattace-Raso F, Sijbrands EJ, D'Arrigo G, Tripepi G, Volpato S, Bandinelli S, Ferrucci L, Zoccali C. Oxidized LDL, Gamma-Glutamyltransferase and Adverse Outcomes in Older Adults. J Am Geriatr Soc 2017;65:e77-82. [PMID: 28422277 DOI: 10.1111/jgs.14566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
193 Dhingra R, Gona P, Wang TJ, Fox CS, D’Agostino RB, Vasan RS. Serum gamma-glutamyl transferase and risk of heart failure in the community. Arterioscler Thromb Vasc Biol. 2010;30:1855-1860. [PMID: 20539015 DOI: 10.1161/atvbaha.110.207340] [Cited by in Crossref: 56] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
194 Xia C, Tong Q, Wang Q, Tang Z, Qi L, Chi S, Zhang M, Wang X, Li H, Xu G. Application of five frozen human-pooled serum samples assigned by the International Federation of Clinical Chemistry and Laboratory Medicine reference procedure in a traceability investigation of γ-glutamyltransferase catalytic concentration measurements in China. Ann Clin Biochem 2010;47:189-94. [DOI: 10.1258/acb.2009.009210] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
195 Sakuta H, Suzuki T, Yyasuda H, Ito T. Vital capacity and selected metabolic diseases in middle-aged Japanese men. Can Respir J 2006;13:79-82. [PMID: 16550264 DOI: 10.1155/2006/892034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
196 Yadav D, Lee MY, Kim JY, Ryu H, Huh JH, Bae KS, Ahn SV, Chung CH, Park JT, Koh SB. Combined Effect of Initial and Longitudinal Increases in γ-Glutamyltransferase on Incident Metabolic Syndrome: ARIRANG Study. Yonsei Med J 2017;58:763-9. [PMID: 28540989 DOI: 10.3349/ymj.2017.58.4.763] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
197 Franzini M, Corti A, Fornaciari I, Balderi M, Torracca F, Lorenzini E, Baggiani A, Pompella A, Emdin M, Paolicchi A. Cultured human cells release soluble gamma-glutamyltransferase complexes corresponding to the plasma b-GGT. Biomarkers. 2009;14:486-492. [PMID: 19863187 DOI: 10.3109/13547500903093757] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
198 Emdin M, Passino C, Donato L, Paolicchi A, Pompella A. Serum Gamma-Glutamyltransferase as a Risk Factor of Ischemic Stroke Might Be Independent of Alcohol Consumption. Stroke 2002;33:1163-4. [DOI: 10.1161/01.str.0000012344.35312.13] [Cited by in Crossref: 41] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
199 Lee CH, Han K, Kim DH, Kwak MS. Repeatedly elevated γ-glutamyltransferase levels are associated with an increased incidence of digestive cancers: A population-based cohort study. World J Gastroenterol 2021; 27(2): 176-188 [PMID: 33510558 DOI: 10.3748/wjg.v27.i2.176] [Reference Citation Analysis]
200 Wannamethee SG, Shaper AG. Cigarette smoking and serum liver enzymes: the role of alcohol and inflammation. Ann Clin Biochem 2010;47:321-6. [PMID: 20511375 DOI: 10.1258/acb.2010.009303] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
201 Yang P, Wu P, Liu X, Feng J, Zheng S, Wang Y, Fan Z. Association Between γ-Glutamyltransferase Level and Cardiovascular or All-Cause Mortality in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis. Angiology 2019;70:844-52. [PMID: 31122026 DOI: 10.1177/0003319719850058] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
202 El Azeem HA, Khalek el-SA, El-Akabawy H, Naeim H, Khalik HA, Alfifi AA. Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events. J Saudi Heart Assoc. 2013;25:239-246. [PMID: 24198448 DOI: 10.1016/j.jsha.2013.07.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
203 Kreutzer F, Krause D, Klaassen-Mielke R, Trampisch HJ, Diehm C, Rudolf H. Gamma-glutamyl transferase as a risk factor for mortality and cardiovascular events in older adults - results from a prospective cohort study in a primary care setting (getABI). Vasa 2019;48:313-9. [PMID: 30994055 DOI: 10.1024/0301-1526/a000790] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
204 Bharani V, Ramesh V, Rao RN, Tewari S. Evaluation of gamma glutamyl transferase as a marker of cardiovascular risk, in 200 angiographically proven coronary artery disease patients. Indian Heart J 2017;69:325-7. [PMID: 28648423 DOI: 10.1016/j.ihj.2017.03.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
205 Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, Blomhoff R, Jacobs DR. Gamma-glutamyltransferase and diabetes--a 4 year follow-up study. Diabetologia. 2003;46:359-364. [PMID: 12687334 DOI: 10.1007/s00125-003-1036-5] [Cited by in Crossref: 210] [Cited by in F6Publishing: 186] [Article Influence: 11.1] [Reference Citation Analysis]
206 Giral P, Ratziu V, Couvert P, Carrié A, Kontush A, Girerd X, Chapman MJ. Plasma bilirubin and gamma-glutamyltransferase activity are inversely related in dyslipidemic patients with metabolic syndrome: Relevance to oxidative stress. Atherosclerosis 2010;210:607-13. [DOI: 10.1016/j.atherosclerosis.2009.12.026] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
207 Devries MC, Samjoo IA, Hamadeh MJ, Tarnopolsky MA. Effect of Endurance Exercise on Hepatic Lipid Content, Enzymes, and Adiposity in Men and Women. Obesity 2008;16:2281-8. [DOI: 10.1038/oby.2008.358] [Cited by in Crossref: 65] [Cited by in F6Publishing: 53] [Article Influence: 6.5] [Reference Citation Analysis]
208 Cho HS, Lee SW, Kim ES, Mo EY, Shin JY, Moon SD, Han JH. Clinical significance of serum bilirubin and gamma-glutamyltransferase levels on coronary atherosclerosis assessed by multidetector computed tomography. Nutr Metab Cardiovasc Dis 2015;25:677-85. [PMID: 26026212 DOI: 10.1016/j.numecd.2015.03.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
209 Seneff S, Davidson RM, Lauritzen A, Samsel A, Wainwright G. A novel hypothesis for atherosclerosis as a cholesterol sulfate deficiency syndrome. Theor Biol Med Model 2015;12:9. [PMID: 26014131 DOI: 10.1186/s12976-015-0006-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
210 Celik O, Cakmak HA, Satilmis S, Gungor B, Akin F, Ozturk D, Yalcin AA, Ayca B, Erturk M, Atasoy MM, Uslu N. The relationship between gamma-glutamyl transferase levels and coronary plaque burdens and plaque structures in young adults with coronary atherosclerosis. Clin Cardiol 2014;37:552-7. [PMID: 25197023 DOI: 10.1002/clc.22307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
211 Zhang H, Forman HJ, Choi J. Gamma-glutamyl transpeptidase in glutathione biosynthesis. Methods Enzymol. 2005;401:468-483. [PMID: 16399403 DOI: 10.1016/s0076-6879(05)01028-1] [Cited by in Crossref: 145] [Cited by in F6Publishing: 72] [Article Influence: 9.1] [Reference Citation Analysis]
212 Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011;43:617-649. [PMID: 21039302 DOI: 10.3109/07853890.2010.518623] [Cited by in Crossref: 770] [Cited by in F6Publishing: 699] [Article Influence: 64.2] [Reference Citation Analysis]
213 Ndrepepa G, Braun S, Schunkert H, Laugwitz KL, Kastrati A. Gamma-glutamyl transferase and prognosis in patients with coronary artery disease. Clin Chim Acta 2016;452:155-60. [PMID: 26581592 DOI: 10.1016/j.cca.2015.11.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
214 Akgul O, Uyarel H. G-glutamyl transferase: a novel prognostic marker for cardiovascular disease. J Crit Care 2014;29:167-8. [PMID: 24331949 DOI: 10.1016/j.jcrc.2013.10.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
215 Mistry D, Stockley RA. Gamma-Glutamyl Transferase: The Silent Partner? COPD: Journal of Chronic Obstructive Pulmonary Disease 2010;7:285-90. [DOI: 10.3109/15412555.2010.496819] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
216 Zhang H, Forman HJ. Redox regulation of gamma-glutamyl transpeptidase. Am J Respir Cell Mol Biol 2009;41:509-15. [PMID: 19684307 DOI: 10.1165/rcmb.2009-0169TR] [Cited by in Crossref: 95] [Cited by in F6Publishing: 38] [Article Influence: 7.3] [Reference Citation Analysis]
217 Kazemi-Shirazi L, Endler G, Winkler S, Schickbauer T, Wagner O, Marsik C. Gamma glutamyltransferase and long-term survival: is it just the liver? Clin Chem 2007;53:940-6. [PMID: 17384006 DOI: 10.1373/clinchem.2006.081620] [Cited by in Crossref: 94] [Cited by in F6Publishing: 92] [Article Influence: 6.3] [Reference Citation Analysis]